Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticlas, related party of Ishita Drugs and Industries Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a related party of Ishita Drugs & Industries Ltd, bought 425 shares of the company in the open market on December 1, 2025. This is a very small purchase, equal to just 0.01% of the company's total equity. After the buy, Ishita Pharmaceuticals' holding rose marginally from 28,334 shares (0.95%) to 28,759 shares (0.96%). The total share capital of the company remains 29,90,300 shares of Rs. 10 each. The disclosure was filed under SEBI Takeover Regulations to keep the stock exchange informed of the transaction.
This is a token-sized acquisition by a related party and has no meaningful effect on the shareholding pattern, control, or stock price. Retail investors need not be concerned — it does not signal any change in promoter intent or corporate direction.